...
首页> 外文期刊>International clinical psychopharmacology >Sleep disturbances and depression: a challenge for antidepressants.
【24h】

Sleep disturbances and depression: a challenge for antidepressants.

机译:睡眠障碍和抑郁:抗抑郁药的挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

Sleep disturbances are commonly experienced by depressed patients, and abnormalities of sleep architecture are among the most robust psychobiological correlates of major depression. Most antidepressants alter the physiological patterns of sleep and eventually improve sleep symptoms, along with other symptoms of depression. However, many antidepressants also have unwanted adverse effects on sleep, notably by causing or worsening insomnia, daytime sleepiness or sedation. This article briefly reviews the biology of sleep, the sleep disturbances associated with depression, and the therapeutic and adverse effects of antidepressants on sleep. It also describes a novel antidepressant, agomelatine, which improves symptoms of depression and rapidly relieves sleep complaints without sedative effects.
机译:抑郁症患者通常会经历睡眠障碍,而睡眠结构异常是重度抑郁症最强大的心理生物学相关因素之一。大多数抗抑郁药会改变睡眠的生理模式,并最终改善睡眠症状以及其他抑郁症状。但是,许多抗抑郁药也会对睡眠产生不良影响,特别是引起或加剧失眠,白天嗜睡或镇静作用。本文简要回顾了睡眠的生物学,与抑郁相关的睡眠障碍以及抗抑郁药对睡眠的治疗和不良影响。它还描述了一种新型的抗抑郁药阿戈美拉汀,该药可改善抑郁症状并迅速缓解睡眠不适,而无镇静作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号